Europe High Potency Active Pharmaceutical Ingredient Market Report 2016

Europe High Potency Active Pharmaceutical Ingredient Market Report 2016

1 High Potency Active Pharmaceutical Ingredient Overview

1.1 Product Overview and Scope of High Potency Active Pharmaceutical Ingredient

1.2 Classification of High Potency Active Pharmaceutical Ingredient

1.2.1 Synthetic

1.2.2 Biotech

1.2.3 Type III

1.3 Application of High Potency Active Pharmaceutical Ingredient

1.3.1 Oncology

1.3.2 Hormonal disorders

1.3.3 Glaucoma

1.3.4 Others

1.4 High Potency Active Pharmaceutical Ingredient Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of High Potency Active Pharmaceutical Ingredient (2011-2021)

1.5.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2021)

1.5.2 Europe High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

2 Europe High Potency Active Pharmaceutical Ingredient by Manufacturers, Type and Application

2.1 Europe High Potency Active Pharmaceutical Ingredient Market Competition by Manufacturers

2.1.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe High Potency Active Pharmaceutical Ingredient Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe High Potency Active Pharmaceutical Ingredient (Volume and Value) by Type

2.2.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2016)

2.2.2 Europe High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2016)

2.3 Europe High Potency Active Pharmaceutical Ingredient (Volume and Value) by Countries

2.3.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Countries (2011-2016)

2.3.2 Europe High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Countries (2011-2016)

2.4 Europe High Potency Active Pharmaceutical Ingredient (Volume) by Application

3 Germany High Potency Active Pharmaceutical Ingredient (Volume, Value and Sales Price)

3.1 Germany High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)

3.1.1 Germany High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

3.1.2 Germany High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

3.1.3 Germany High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

3.2 Germany High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers

3.3 Germany High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type

3.4 Germany High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

4 France High Potency Active Pharmaceutical Ingredient (Volume, Value and Sales Price)

4.1 France High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)

4.1.1 France High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

4.1.2 France High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

4.1.4 France High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

4.2 France High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers

4.3 France High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type

4.4 France High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

5 UK High Potency Active Pharmaceutical Ingredient (Volume, Value and Sales Price)

5.1 UK High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)

5.1.1 UK High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

5.1.2 UK High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

5.1.5 UK High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

5.2 UK High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers

5.3 UK High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type

5.4 UK High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

6 Russia High Potency Active Pharmaceutical Ingredient (Volume, Value and Sales Price)

6.1 Russia High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)

6.1.1 Russia High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

6.1.2 Russia High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

6.1.6 Russia High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

6.2 Russia High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers

6.3 Russia High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type

6.4 Russia High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

7 Italy High Potency Active Pharmaceutical Ingredient (Volume, Value and Sales Price)

7.1 Italy High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)

7.1.1 Italy High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

7.1.2 Italy High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

7.1.7 Italy High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

7.2 Italy High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers

7.3 Italy High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type

7.4 Italy High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

8 Spain High Potency Active Pharmaceutical Ingredient (Volume, Value and Sales Price)

8.1 Spain High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)

8.1.1 Spain High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

8.1.2 Spain High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

8.1.8 Spain High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

8.2 Spain High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers

8.3 Spain High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type

8.4 Spain High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

9 Benelux High Potency Active Pharmaceutical Ingredient (Volume, Value and Sales Price)

9.1 Benelux High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)

9.1.1 Benelux High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

9.1.2 Benelux High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

9.1.9 Benelux High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

9.2 Benelux High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers

9.3 Benelux High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type

9.4 Benelux High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

10 Europe High Potency Active Pharmaceutical Ingredient Manufacturers Analysis

10.1 Alkermes

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Alkermes High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Cambex

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 Cambex High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Dr. Reddy’s Labotatories

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Lonza Group

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Lonza Group High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Novasep

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Novasep High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Sandoz

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Sandoz High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

...

11 High Potency Active Pharmaceutical Ingredient Manufacturing Cost Analysis

11.1 High Potency Active Pharmaceutical Ingredient Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe High Potency Active Pharmaceutical Ingredient Market Forecast (2016-2021)

14.1 Germany High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)

14.2 France High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)

14.3 UK High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)

14.4 Russia High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)

14.5 Italy High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)

14.6 Spain High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)

14.7 Benelux High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)

14.8 Europe High Potency Active Pharmaceutical Ingredient Sales Forecast by Type (2016-2021)

14.9 Europe High Potency Active Pharmaceutical Ingredient Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of High Potency Active Pharmaceutical Ingredient

Table Classification of High Potency Active Pharmaceutical Ingredient

Figure Europe Sales Market Share of High Potency Active Pharmaceutical Ingredient by Type in 2015

Figure Synthetic Picture

Figure Biotech Picture

Table Application of High Potency Active Pharmaceutical Ingredient

Figure Europe Sales Market Share of High Potency Active Pharmaceutical Ingredient by Application in 2015

Figure Oncology Examples

Figure Hormonal disorders Examples

Figure Glaucoma Examples

Figure Others Examples

Figure Germany High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

Figure France High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

Figure UK High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

Figure Russia High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

Figure Italy High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

Figure Spain High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

Figure Benelux High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

Figure Europe High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2021)

Figure Europe High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

Table Europe High Potency Active Pharmaceutical Ingredient Sales of Key Manufacturers (2015 and 2016)

Table Europe High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015 and 2016)

Figure 2015 High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers

Figure 2016 High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers

Table Europe High Potency Active Pharmaceutical Ingredient Revenue by Manufacturers (2015 and 2016)

Table Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers

Table 2016 Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers

Table Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2016)

Table Europe High Potency Active Pharmaceutical Ingredient Sales Share by Type (2011-2016)

Figure Sales Market Share of High Potency Active Pharmaceutical Ingredient by Type (2011-2016)

Figure Europe High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Type (2011-2016)

Table Europe High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2016)

Table Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Type (2011-2016)

Figure Revenue Market Share of High Potency Active Pharmaceutical Ingredient by Type (2011-2016)

Figure Europe High Potency Active Pharmaceutical Ingredient Revenue Growth Rate by Type (2011-2016)

Table Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Countries (2011-2016)

Table Europe High Potency Active Pharmaceutical Ingredient Sales Share by Countries (2011-2016)

Figure Sales Market Share of High Potency Active Pharmaceutical Ingredient by Countries (2011-2016)

Table Europe High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Countries (2011-2016)

Table Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of High Potency Active Pharmaceutical Ingredient by Countries (2011-2016)

Table Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application (2011-2016)

Table Europe High Potency Active Pharmaceutical Ingredient Sales Share by Application (2011-2016)

Figure Sales Market Share of High Potency Active Pharmaceutical Ingredient by Application (2011-2016)

Figure Germany High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

Figure Germany High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

Figure Germany High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

Table Germany High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)

Table Germany High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)

Table Germany High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)

Table Germany High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)

Table Germany High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)

Table Germany High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)

Figure France High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

Figure France High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

Figure France High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

Table France High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)

Table France High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)

Table France High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)

Table France High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)

Table France High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)

Table France High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)

Figure UK High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

Figure UK High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

Figure UK High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

Table UK High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)

Table UK High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)

Table UK High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)

Table UK High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)

Table UK High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)

Table UK High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)

Figure Russia High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

Figure Russia High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

Figure Russia High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

Table Russia High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)

Table Russia High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)

Table Russia High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)

Table Russia High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)

Table Russia High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)

Table Russia High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)

Figure Italy High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

Figure Italy High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

Figure Italy High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

Table Italy High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)

Table Italy High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)

Table Italy High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)

Table Italy High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)

Table Italy High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)

Table Italy High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)

Figure Spain High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

Figure Spain High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

Figure Spain High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

Table Spain High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)

Table Spain High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)

Table Spain High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)

Table Spain High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)

Table Spain High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)

Table Spain High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)

Figure Benelux High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)

Figure Benelux High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)

Figure Benelux High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)

Table Benelux High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)

Table Benelux High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)

Table Benelux High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)

Table Benelux High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)

Table Benelux High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)

Table Benelux High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)

Table High Potency Active Pharmaceutical Ingredient Basic Information List

Table Alkermes High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Alkermes High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Cambex Basic Information List

Table Cambex High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cambex High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Dr. Reddy’s Labotatories Basic Information List

Table Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Lonza Group Basic Information List

Table Lonza Group High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lonza Group High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Novasep Basic Information List

Table Novasep High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novasep High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Sandoz Basic Information List

Table Sandoz High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sandoz High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of High Potency Active Pharmaceutical Ingredient

Figure Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient

Figure High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis

Table Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015

Table Major Buyers of High Potency Active Pharmaceutical Ingredient

Table Distributors/Traders List

Figure Germany High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)

Figure Germany High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)

Figure France High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)

Figure France High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)

Figure UK High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)

Figure UK High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)

Figure Russia High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)

Figure Russia High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)

Figure Italy High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)

Figure Italy High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)

Figure Spain High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)

Figure Spain High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)

Figure Benelux High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)

Table Europe High Potency Active Pharmaceutical Ingredient Sales Forecast by Type (2016-2021)

Table Europe High Potency Active Pharmaceutical Ingredient Sales Forecast by Application (2016-2021)